First-in-Human (FIH) Study of the Xeltis Hemodialysis Access Graft

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 10, 2021

Primary Completion Date

March 24, 2023

Study Completion Date

September 30, 2027

Conditions

End Stage Renal DiseaseEnd Stage Renal Failure on Dialysis

Interventions

DEVICE

aXess

Patients will be implanted with one Xeltis hemodialysis access device (aXess) in the arm

Trial Locations (6)

A.Z. Sint Jan, Bruges

Ziekenhuis Oost-Limburg, Genk

UZ Ghent, Ghent

Universita degli studi dell'Insubria, Varese

P. Stradins Clinical University Hospital, Riga

Vilnius University Hospital Santaros Klinikos Corpus A., Vilnius